Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub-study

Laura S.M. Kerkmeijer, Ruben Y.G. Tijssen, Sjoerd H. Hofma, Rene J. van der Schaaf, E. Karin Arkenbout, Auke P.J.D. Weevers, Robin P. Kraak, Yoshinobu Onuma, Patrick W. Serruys, Jan J. Piek, Jan G.P. Tijssen, Jose P.S. Henriques, Robbert J. de Winter, Joanna J. Wykrzykowska*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
58 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub-study'. Together they form a unique fingerprint.

Medicine and Dentistry